Finally, noncoding expansions in GLS (glutaminase, MIM #138280) in patients with global developmental delay, progressive ataxia, and elevated plasma glutamine (GDPAG, MIM #618412) were identified thanks to their associated biochemical phenotype. This evidence concerns the gene GLS and Ataxia.